Patent 7795448 was granted and assigned to Cytokinetics on September, 2010 by the United States Patent and Trademark Office.
Provided are compounds of Formula V and pharmaceutically acceptable salts thereof which may be useful for the treatment of cancer or other proliferative disorders.